5-(6-chloro-pyridazin-3-yl)-2-[3-((R)-2-methyl-pyrrolidin-1-yl)-propoxy]-benzonitrile | 1174674-69-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 5-(6-chloro-pyridazin-3-yl)-2-[3-((R)-2-methyl-pyrrolidin-1-yl)-propoxy]-benzonitrile
• 英文别名: 5-(6-chloropyridazin-3-yl)-2-[3-[(2R)-2-methylpyrrolidin-1-yl]propoxy]benzonitrile
• CAS: 1174674-69-1
• 化学式: C₁₉H₂₁ClN₄O
• 分子量: 356.855
• InChiKey: DKXPWQDBPJOGQW-CQSZACIVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  25
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  62
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  5-(6-chloro-pyridazin-3-yl)-2-[3-((R)-2-methyl-pyrrolidin-1-yl)-propoxy]-benzonitrile 生成 2-[3-((R)-2-methyl-pyrrolidin-1-yl)-propoxy]-5-(6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile
  参考文献：
  名称：

  Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity

  摘要：

  H3R structure-activity relationships on a novel class of pyridazin-3-one H3R antagonists/inverse agonists are disclosed. Modifications of the pyridazinone core, central phenyl ring and linker led to the identification of molecules with excellent target potency, selectivity and pharmacokinetic properties. Compounds 13 and 21 displayed potent functional H3R antagonism in vivo in the rat dipsogenia model and demonstrated robust wake activity in the rat EEG/EMG model. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.06.108
• 作为产物：
  描述：

  3,6-二氯哒嗪 、 5-boranyl-2-[3-((R)-2-methyl-pyrrolidin-1-yl)-propoxy]-benzonitrile 生成 5-(6-chloro-pyridazin-3-yl)-2-[3-((R)-2-methyl-pyrrolidin-1-yl)-propoxy]-benzonitrile
  参考文献：
  名称：

  Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity

  摘要：

  H3R structure-activity relationships on a novel class of pyridazin-3-one H3R antagonists/inverse agonists are disclosed. Modifications of the pyridazinone core, central phenyl ring and linker led to the identification of molecules with excellent target potency, selectivity and pharmacokinetic properties. Compounds 13 and 21 displayed potent functional H3R antagonism in vivo in the rat dipsogenia model and demonstrated robust wake activity in the rat EEG/EMG model. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.06.108

文献信息

• [EN] SUBSTITUTED PYRIDAZINE DERIVATIVES WHICH HAVE HISTAMINE H3 ANTAGONIST ACTIVITY<br/>[FR] DÉRIVÉS DE PYRIDAZINE SUBSTITUÉS À ACTIVITÉ ANTAGONISTE DES RÉCEPTEURS H3 DE L'HISTAMINE
  申请人：CEPHALON INC

  公开号：WO2009097306A1

  公开（公告）日：2009-08-06

  The present invention is directed to compounds having histamine H3 antagonist activity, as well as methods of their use and preparation.

  本发明涉及具有组胺H3拮抗活性的化合物，以及它们的使用和制备方法。
• Substituted Pyridazine Derivatives
  申请人：Hudkins Robert L.

  公开号：US20120004231A1

  公开（公告）日：2012-01-05

  The present invention is directed to compounds having histamine H 3 antagonist activity, as well as methods of their use and preparation.

  本发明涉及具有组胺H3拮抗活性的化合物，以及它们的使用和制备方法。
• Substituted pyridazine derivatives
  申请人：Hudkins Robert L.

  公开号：US20100311752A1

  公开（公告）日：2010-12-09

  The present invention is directed to compounds having histamine H 3 antagonist activity, as well as methods of their use and preparation.

  本发明涉及具有组胺H3受体拮抗活性的化合物，以及它们的使用和制备方法。
• Substituted pyridazine derivatives which have histamine H3 antagonist activity
  申请人：CEPHALON, INC.

  公开号：EP2752406A1

  公开（公告）日：2014-07-09

  The present invention is directed to compounds of formula (I) having histamine H3 antagonist activity, as well as methods of their use and preparation. A compound of Formula I:

  本发明涉及具有组胺 H3 拮抗剂活性的式 (I) 化合物及其使用和制备方法。 式 I 的化合物
• SUBSTITUTED PYRIDAZINE DERIVATIVES WHICH HAVE HISTAMINE H3 ANTAGONIST ACTIVITY
  申请人：Cephalon, Inc.

  公开号：EP2252593A1

  公开（公告）日：2010-11-24